You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 00536-1269


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00536-1269

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for NDC 00536-1269

Understanding NDC Numbers

To delve into the market analysis and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand the significance of NDC numbers. NDC numbers are unique identifiers that help in tracking, inventory management, and ensuring the quality and safety of medications. Each NDC number consists of three segments: the labeler code, the product code, and the package code, which collectively provide a standardized way to identify and track medications[1].

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant transformations driven by digital advancements, scientific innovations, and regulatory changes.

Pricing and Access

Pricing and access to drugs are among the most significant issues facing the life sciences industry. Nearly half of the C-suite executives surveyed expect pricing and access to significantly impact their strategies in 2025. This trend is exacerbated by the high prices of prescription drugs in the U.S., which are 2.78 times higher than in other OECD countries[3][4].

Generic and Biosimilar Competition

Competition from generic drugs and biosimilars is another key trend. The patent cliff, with over $300 billion in sales at risk through 2030 due to expiring patents, is likely to drive interest in mergers and acquisitions and the development of new drugs[3].

Price Projections for Prescription Drugs

Overall Market Trends

The overall drug price inflation rate for 2025 is projected to be 3.81%, according to Vizient's summer Pharmacy Market Outlook for 2024. This projection indicates a moderate increase in drug prices, which can be influenced by various factors including supply chain dynamics, regulatory oversight, and market competition[5].

Specific Drug Pricing

For the NDC 00536-1269, specific price data may not be readily available in the provided sources. However, we can infer from general trends:

  • Price Inflation: Given the projected 3.81% inflation rate, it is likely that the price of the drug identified by NDC 00536-1269 will increase accordingly.
  • Supply Chain Factors: The price can be influenced by supply chain issues, such as procurement costs, distribution efficiencies, and regulatory compliance. NDC numbers play a crucial role in optimizing supply chains by facilitating seamless communication between suppliers, manufacturers, distributors, and pharmacies[1].
  • Market Competition: The presence of generic or biosimilar alternatives can impact the pricing strategy for the drug. If there are no direct competitors, the price may remain relatively stable or increase based on market demand and the drug's unique attributes[3].

Regulatory and Transparency Factors

Price Transparency

Regulatory measures such as those implemented in Oregon aim to increase price transparency across the pharmaceutical supply chain. Manufacturers are required to report price increases and new high-cost drugs, which can impact the pricing strategy for any drug, including the one identified by NDC 00536-1269[2].

Regulatory Oversight

The FDA's requirements and state-level regulations can also influence pricing. For instance, the Prescription Drug Affordability Board in Oregon can study drug costs and perform affordability reviews, which might lead to upper payment limits for certain drugs. Although this is not yet implemented, it could be a future consideration for pricing strategies[2].

Data-Driven Insights

Pharmaceutical companies can gain valuable insights into market trends, demand patterns, and medication performance by analyzing NDC data. This information can be used to develop targeted marketing strategies, identify niche markets, and tailor messaging to specific patient populations. For the drug with NDC 00536-1269, analyzing such data can help in predicting market demand and adjusting pricing accordingly[1].

Conclusion

The market analysis and price projections for the drug identified by NDC 00536-1269 are influenced by a combination of factors including overall market trends, supply chain dynamics, regulatory oversight, and competition. Here are some key points to consider:

  • Price Inflation: A projected 3.81% increase in drug prices for 2025.
  • Supply Chain Optimization: NDC numbers facilitate efficient supply chain management.
  • Regulatory Transparency: State and federal regulations aim to increase price transparency.
  • Market Competition: The presence of generic or biosimilar alternatives can impact pricing.
  • Data-Driven Insights: Analyzing NDC data can provide valuable market insights.

Key Takeaways

  • Standardized Identification: NDC numbers are crucial for accurate tracking and inventory management.
  • Market Trends: The pharmaceutical industry faces significant pricing and access challenges.
  • Regulatory Impact: Transparency and regulatory oversight can influence pricing strategies.
  • Data Analysis: NDC data provides insights into market trends and demand patterns.
  • Supply Chain Efficiency: NDC numbers optimize supply chain communication and efficiency.

FAQs

1. What is the significance of NDC numbers in the pharmaceutical industry? NDC numbers provide a standardized way to identify and track medications, ensuring accurate tracking, inventory management, and preventing medication errors[1].

2. How do regulatory measures impact drug pricing? Regulatory measures such as price transparency programs and affordability reviews can influence pricing strategies by requiring manufacturers to report price increases and ensuring that prices are reasonable and transparent[2].

3. What is the projected drug price inflation rate for 2025? The overall drug price inflation rate for 2025 is projected to be 3.81% according to Vizient's summer Pharmacy Market Outlook for 2024[5].

4. How does competition from generic drugs affect pricing? Competition from generic drugs and biosimilars can significantly impact pricing strategies, as it introduces cheaper alternatives that can reduce the market price of branded drugs[3].

5. What role do NDC numbers play in optimizing supply chains? NDC numbers facilitate seamless communication between suppliers, manufacturers, distributors, and pharmacies, helping to streamline the procurement process, reduce lead times, and enhance overall supply chain visibility[1].

Sources

  1. Quality Smart Solutions: "Why NDC Numbers are vital for pharmaceutical companies?"
  2. Oregon Department of Consumer and Business Services: "Prescription Drug Price Transparency Results and Recommendations"
  3. Deloitte Insights: "2025 life sciences outlook"
  4. ASPE: "International Market Size and Prices for Prescription Drugs"
  5. DrugPatentWatch: "Latest drug prices and trends for NDC 00115-1320"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.